2Xideas AG Acquires 25,887 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

2Xideas AG boosted its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 29.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 113,781 shares of the medical device company's stock after buying an additional 25,887 shares during the quarter. 2Xideas AG owned about 0.06% of Cooper Companies worth $10,460,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Aster Capital Management DIFC Ltd lifted its stake in shares of Cooper Companies by 1,048.5% in the fourth quarter. Aster Capital Management DIFC Ltd now owns 3,457 shares of the medical device company's stock worth $318,000 after buying an additional 3,156 shares during the last quarter. Wedbush Securities Inc. raised its holdings in Cooper Companies by 10.4% in the 4th quarter. Wedbush Securities Inc. now owns 11,910 shares of the medical device company's stock worth $1,095,000 after acquiring an additional 1,120 shares during the period. Resona Asset Management Co. Ltd. acquired a new position in Cooper Companies during the 4th quarter worth $5,520,000. Motley Fool Asset Management LLC boosted its holdings in Cooper Companies by 2.4% during the fourth quarter. Motley Fool Asset Management LLC now owns 72,093 shares of the medical device company's stock valued at $6,628,000 after acquiring an additional 1,668 shares during the period. Finally, Headlands Technologies LLC boosted its holdings in Cooper Companies by 28.0% during the fourth quarter. Headlands Technologies LLC now owns 50,754 shares of the medical device company's stock valued at $4,666,000 after acquiring an additional 11,099 shares during the period. 24.39% of the stock is currently owned by institutional investors.

Remove Ads

Cooper Companies Stock Performance

Cooper Companies stock traded up $1.49 on Friday, hitting $76.86. The company's stock had a trading volume of 884,647 shares, compared to its average volume of 1,385,207. The Cooper Companies, Inc. has a one year low of $69.81 and a one year high of $112.38. The firm has a market cap of $15.37 billion, a P/E ratio of 39.05, a price-to-earnings-growth ratio of 2.25 and a beta of 1.01. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The company has a fifty day moving average price of $84.99 and a 200-day moving average price of $94.84.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, meeting the consensus estimate of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The business had revenue of $964.70 million for the quarter, compared to analyst estimates of $981.25 million. On average, equities analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on COO. Stifel Nicolaus cut their price objective on Cooper Companies from $115.00 to $105.00 and set a "buy" rating for the company in a research report on Friday, March 7th. BNP Paribas upgraded Cooper Companies to a "hold" rating in a report on Thursday, March 13th. JPMorgan Chase & Co. lowered their price objective on shares of Cooper Companies from $120.00 to $110.00 and set an "overweight" rating on the stock in a research note on Friday, March 7th. Piper Sandler reiterated an "overweight" rating and set a $115.00 target price (down from $120.00) on shares of Cooper Companies in a research note on Friday, March 7th. Finally, Needham & Company LLC reissued a "hold" rating on shares of Cooper Companies in a report on Friday, March 7th. Four research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $110.25.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.